These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 8453315)
1. Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker. Ritchie DM; Kirchner T; Moore JB; Dodd JH; Ahmed T; Anderson DW; Capetola RJ Int Arch Allergy Immunol; 1993; 100(3):274-82. PubMed ID: 8453315 [TBL] [Abstract][Full Text] [Related]
2. RWJ-22108--a novel airway tissue--selective calcium channel blocker. Moore JB; Miller WC; Mockoviak S Agents Actions; 1993 Sep; 40(1-2):57-61. PubMed ID: 8147270 [TBL] [Abstract][Full Text] [Related]
3. The role of calcium antagonists in bronchial reactivity. Ahmed T; D'Brot J; Abraham W J Allergy Clin Immunol; 1988 Jan; 81(1):133-44. PubMed ID: 3276758 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker. Dodd JH; Schwender CF; Conley RA; Moore JB; Ritchie DM; Fabian AC; Fenk CJ; Bourcet E; Gray-Nunez Y; Kirchner T Drug Des Discov; 1993; 10(1):65-75. PubMed ID: 8399994 [No Abstract] [Full Text] [Related]
5. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137 [TBL] [Abstract][Full Text] [Related]
6. Effects of Y-27632, a Rho/Rho kinase inhibitor, on leukotriene D(4)- and histamine-induced airflow obstruction and airway microvascular leakage in guinea pigs in vivo. Tokuyama K; Nishimura H; Iizuka K; Kato M; Arakawa H; Saga R; Mochizuki H; Morikawa A Pharmacology; 2002 Apr; 64(4):189-95. PubMed ID: 11893899 [TBL] [Abstract][Full Text] [Related]
7. Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blocker. Dodd JH; Schwender CF; Moore JB; Ritchie DM; Gray-Nunez Y; Loughney D; Kirchner T; Miller WC; Mockoviak S Drug Des Discov; 1998 May; 15(3):135-48. PubMed ID: 9689497 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of effects of nifedipine on isolated guinea-pig and rat tracheal smooth muscle. Cheng JB; Townley RG Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):228-44. PubMed ID: 6349566 [TBL] [Abstract][Full Text] [Related]
9. Effect of gallopamil, a calcium channel blocker, on carbachol- and histamine-induced bronchoconstriction in sheep. Carpenter N; D'Brot J; Kim CS; Abraham WM; Ahmed T J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):859-66. PubMed ID: 3372909 [TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous and aerosol nifedipine on prostaglandin F2 alpha and histamine-induced bronchoconstriction in anesthetized dogs. Malo PE; Wasserman MA; Griffin RL J Pharmacol Exp Ther; 1982 May; 221(2):410-5. PubMed ID: 6951996 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of aerosol administration of a sulfidopeptide leukotriene antagonist on bronchoconstriction induced by antigen inhalation in guinea pigs. Bando T; Fujimura M; Shintani H; Saito M; Kurashima K; Nishi K; Matsuda T Arzneimittelforschung; 1994 Jun; 44(6):754-7. PubMed ID: 8053975 [TBL] [Abstract][Full Text] [Related]
12. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs. Aoki M; Yamamoto S; Kobayashi M; Ohga K; Kanoh H; Miyata K; Honda K; Yamada T J Pharmacol Exp Ther; 2001 Apr; 297(1):165-73. PubMed ID: 11259541 [TBL] [Abstract][Full Text] [Related]
13. Effects of Ca2+ antagonist, nicardipine, on experimental asthma with special reference to slow reacting substance of anaphylaxis. Koshino T; Fujimura M; Nishioka S; Okafuji K; Minami S; Kanamori K; Matsuda T; Ishizaki T; Saga T; Miyabo S Allergy; 1985 Jul; 40(5):311-3. PubMed ID: 4037252 [TBL] [Abstract][Full Text] [Related]
14. The suppressive effects of YM-58483/BTP-2, a store-operated Ca2+ entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Ohga K; Takezawa R; Yoshino T; Yamada T; Shimizu Y; Ishikawa J Pulm Pharmacol Ther; 2008; 21(2):360-9. PubMed ID: 17977764 [TBL] [Abstract][Full Text] [Related]
15. Calcium-channel blockers in prophylaxis and treatment of asthma. Fanta CH Am J Cardiol; 1985 Jan; 55(3):202B-209B. PubMed ID: 3881915 [TBL] [Abstract][Full Text] [Related]
16. Effect of calcium antagonist gallopamil on antigen-induced early and late bronchoconstrictor responses in allergic sheep. D'Brot J; Abraham WM; Ahmed T Am Rev Respir Dis; 1989 Apr; 139(4):915-20. PubMed ID: 2930069 [TBL] [Abstract][Full Text] [Related]
17. Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study. Girodet PO; Dournes G; Thumerel M; Begueret H; Dos Santos P; Ozier A; Dupin I; Trian T; Montaudon M; Laurent F; Marthan R; Berger P Am J Respir Crit Care Med; 2015 Apr; 191(8):876-83. PubMed ID: 25633090 [TBL] [Abstract][Full Text] [Related]
18. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322 [TBL] [Abstract][Full Text] [Related]
19. Comparative modification of antigen-induced bronchoconstriction by the calcium antagonists, nifedipine and verapamil. Russi EW; Danta I; Ahmed T Chest; 1985 Jul; 88(1):74-8. PubMed ID: 4006559 [TBL] [Abstract][Full Text] [Related]
20. Nifedipine inhibits human bronchial smooth muscle contractions induced by leukotrienes C4 and D4, prostaglandin F2 alpha, and potassium. Kohrogi H; Horio S; Ando M; Sugimoto M; Honda I; Araki S Am Rev Respir Dis; 1985 Aug; 132(2):299-304. PubMed ID: 3861111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]